Susquehanna International Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$833K Buy
30,790
+19,409
+171% +$652K ﹤0.01% 8378
2025
Q4
$487K Sell
11,381
-18,501
-62% -$697K ﹤0.01% 8844
2025
Q3
$847K Sell
29,882
-74
-0.2% -$2.21K ﹤0.01% 7737
2025
Q2
$561K Sell
29,956
-997
-3% -$18.9K ﹤0.01% 8899
2025
Q1
$557K Sell
30,953
-9,624
-24% -$195K ﹤0.01% 8663
2024
Q4
$683K Buy
40,577
+25,012
+161% +$480K ﹤0.01% 7881
2024
Q3
$252K Sell
15,565
-1,897
-11% -$22.3K ﹤0.01% 9990
2024
Q2
$144K Buy
17,462
+4,067
+30% +$42.6K ﹤0.01% 10736
2024
Q1
$198K Sell
13,395
-16,601
-55% -$224K ﹤0.01% 10605
2023
Q4
$435K Buy
29,996
+5,183
+21% +$53K ﹤0.01% 9008
2023
Q3
$268K Sell
24,813
-52,970
-68% -$637K ﹤0.01% 9605
2023
Q2
$1M Buy
77,783
+61,112
+367% +$826K ﹤0.01% 6667
2023
Q1
$220K Sell
16,671
-3,367
-17% -$53.5K ﹤0.01% 10389
2022
Q4
$301K Buy
20,038
+8,182
+69% +$75K ﹤0.01% 9094
2022
Q3
$140K Sell
11,856
-19,340
-62% -$262K ﹤0.01% 11332
2022
Q2
$353K Buy
31,196
+11,981
+62% +$241K ﹤0.01% 9128
2022
Q1
$575K Sell
19,215
-32,917
-63% -$891K ﹤0.01% 8614
2021
Q4
$1.38M Buy
52,132
+12,387
+31% +$374K ﹤0.01% 6416
2021
Q3
$1.44M Sell
39,745
-7,537
-16% -$297K ﹤0.01% 6584
2021
Q2
$2.05M Buy
47,282
+19,255
+69% +$727K ﹤0.01% 5863
2021
Q1
$959K Buy
28,027
+7,449
+36% +$295K ﹤0.01% 7853
2020
Q4
$720K Sell
20,578
-8,842
-30% -$256K ﹤0.01% 7470
2020
Q3
$706K Buy
29,420
+21,879
+290% +$537K ﹤0.01% 6947
2020
Q2
$138K Sell
7,541
-775
-9% -$13.9K ﹤0.01% 9319
2020
Q1
$130K Buy
8,316
+4,853
+140% +$103K ﹤0.01% 9115
2019
Q4
$74K Sell
3,463
-5,804
-63% -$119K ﹤0.01% 9239
2019
Q3
$173K Sell
9,267
-4,149
-31% -$85.7K ﹤0.01% 9222
2019
Q2
$350K Buy
+13,416
New +$303K ﹤0.01% 8013
2019
Q1
Sell
-20,741
Closed -$474K 10208
2018
Q4
$477K Buy
+20,741
New +$585K ﹤0.01% 6125
2018
Q1
Sell
-5,253
Closed -$210K 10422
2017
Q4
$204K Buy
5,253
+3,379
+180% +$129K ﹤0.01% 8252
2017
Q3
$48K Sell
1,874
-9,838
-84% -$239K ﹤0.01% 8549
2017
Q2
$320K Buy
11,712
+5,853
+100% +$160K ﹤0.01% 7468
2017
Q1
$194K Sell
5,859
-16,355
-74% -$417K ﹤0.01% 8023
2016
Q4
$529K Buy
22,214
+15,941
+254% +$457K ﹤0.01% 6856
2016
Q3
$230K Sell
6,273
-5,000
-44% -$143K ﹤0.01% 7358
2016
Q2
$251K Buy
11,273
+8,088
+254% +$201K ﹤0.01% 7248
2016
Q1
$66K Buy
3,185
+686
+27% +$16.9K ﹤0.01% 8590
2015
Q4
$76K Buy
2,499
+804
+47% +$24.4K ﹤0.01% 8979
2015
Q3
$42K Sell
1,695
-3,959
-70% -$118K ﹤0.01% 9398
2015
Q2
$182K Buy
5,654
+1,508
+36% +$57.6K ﹤0.01% 9359
2015
Q1
$148K Buy
4,146
+1,302
+46% +$35.7K ﹤0.01% 8814
2014
Q4
$65K Sell
2,844
-367
-11% -$7.42K ﹤0.01% 9309
2014
Q3
$62K Sell
3,211
-1,897
-37% -$53.6K ﹤0.01% 9181
2014
Q2
$185K Buy
5,108
+538
+12% +$18.3K ﹤0.01% 9130
2014
Q1
$177K Sell
4,570
-24,396
-84% -$870K ﹤0.01% 8319
2013
Q4
$825K Buy
28,966
+26,230
+959% +$770K ﹤0.01% 5833
2013
Q3
$98K Sell
2,736
-1,080
-28% -$39.4K ﹤0.01% 8092
2013
Q2
$127K Buy
+3,816
New +$173K ﹤0.01% 7703

Other funds holding RIGL